CureMetrix is committed to advancing technology that improves disease detection and cancer survival rates worldwide. Specializing in AI-based products and research, CureMetrix focuses on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on.

The company's powerful image analysis platform serves as an adjunct, precision tool for mammography. CureMetrix aims to equip radiologists with objective, data-driven answers to support patients and healthcare teams in making informed health decisions. Their belief is that providing radiologists with advanced technology for mammogram evaluation leads to improved clinical outcomes, reduced healthcare costs, and increased assurance of the highest standard of care for patients.

Founded in 2014, CureMetrix builds products with high efficacy that are easy to install, operate within existing clinical workflows, and minimize extra steps for radiologists and patients. It has partnered with practicing radiologists, cardiologists, and esteemed institutions worldwide to collect over 5 million images to train and validate their algorithms. Their AI technology aims to improve outcomes for diseases such as breast cancer, heart disease, and kidney disease, thereby extending the impact and value of screening programs globally.

CureMetrix's mission centers on saving lives and supporting better clinical and financial outcomes, especially in women's health. Their AI-powered software solutions enable mammograms to detect multiple conditions, such as breast cancer and breast arterial calcifications (BAC), in a single exam without adding radiation or disrupting existing workflows.

The company prioritizes improving healthcare globally, with focused efforts on earlier and more accurate disease detection, reducing healthcare costs, enhancing workflow efficiency, and improving clinical efficiency for radiologists.

Located in San Diego, CA, CureMetrix operates as a privately held company with specialties in mammography, healthcare, women's health, imaging, breast cancer, artificial intelligence, deep learning, computer software, and healthcare technology.